Your Location:
Home >
Browse articles >
Differentiation and Treatment of Vulnerable Atherosclerotic Plaque Based on "Collateral Disease" Theory
Differentiation and Treatment of Vulnerable Atherosclerotic Plaque Based on "Collateral Disease" Theory
Enhanced Publication- “The collateral disease theory provides a new idea for the prevention and treatment of vulnerable atherosclerotic plaques. Experts explore the commonness of venation and physiological neovascularization from a microscopic perspective, dig out the similarities between diseased collateral and pathological neovascularization, and propose the treatment principle of "collateral disease should be unblocked and replenished", which opens a new direction for the prevention and treatment of cardiovascular events by combining traditional Chinese and western medicine.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 16, Pages: 275-284(2026)
DOI: 10.13422/j.cnki.syfjx.20252292
Revised:2025-07-01 ,
Accepted:24 July 2025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 1 ) Tabs( 2 )
References
Publication Info
Metrics
222
Views
164
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanism of Wendan Tang Against Atherosclerosis by Regulating Ferroptosis Based on JAK2/STAT3 Signaling Pathway
Iron Homeostasis Imbalance Promotes Atherosclerosis and Therapeutic Mechanisms of Traditional Chinese Medicine
Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics
Effect and Molecular Mechanisms of Danlou Tablet on Hepatic Lipid Deposition in ApoE-/- Atherosclerotic Mice Through Regulation of SIRT6/CREB/Nor1 Signaling Pathway-mediated Autophagy
Mechanism of Xixintang in Protecting Blood-brain Barrier in Alzheimer's Disease Model Rats Based on AQP4 Polarization
Related Author
LI Yunlun
QIU Tingting
OUYANG Xiaoqiang
FANG Bangjiang
WANG Maohong
XIONG Jianhua
ZHANG Hao
YAN Xiaohong
Related Institution
Jiangxi University of Chinese Medicine
The Affiliated Hospital of Jiangxi University of Chinese Medicine
Longhua Hospital Shanghai University of Traditional Chinese Medicine
School of Chinese Materia Medica,Guangzhou University of Chinese Medicine
Baiyunshan Pharmaceutical General Factory, Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.


